Dept. of Pharmacology Faculty of Medicine AIMST

Slides:



Advertisements
Similar presentations
Antiarrhythmic Drugs.
Advertisements

Antiarrhythmic drugs.
Or Doing Drugs for Your Heartbeat
Anti-arrhythmic drugs
Na+ channel blocker: Na+ channel block depends on: HR
Mechanisms of cardiac arrhythmias
ANTIARRHYTHMIC DRUGS Arrhythmia or dysrhythmia means an abnormal or irregular heart beat Arrhythmias may originate in the atria, SA node or AV node, whereby.
Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.
ANTIARRHYTHMIC DRUGS Arrhythmia/ dysrhythmia means an abnormal or irregular heart beat Arrhythmias may originate in the atria, SA node or AV node, whereby.
October 6, 2006 Frank F. Vincenzi
Cardiac Arrhythmias.
Pharmacology in Nursing Antidysrhythmic Drugs
Drugs used to treat cardiac arrhythmias
Arrhythmia Arrhythmias are abnormal beats of the heart.
ANTI-ARRHYTHMIC DRUGS
Antiarrhythmic Drugs.
Anti-arrhythmic drugs
Anti arrhythmic Drugs Marwa A. Khairy , MD.
Antiarrhythmic drugs Pharma team.
Clinical Use of Antiarrhythmic Agents
ANTIARRHYTHMIC DRUGS 1. INTRODUCTION The heart contains specialized cells that exhibit automaticity; that is, they can generate rhythmic action potentials.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 49 Antidysrhythmic Drugs.
Agents used to treat Arrhythmias Dr. Thomas Abraham PHAR417: Fall 2005.
ANTIARRHYTHMIC DRUGS Department of Pharmacology and Toxicology
© Assoc. Prof. Ivan Lambev
Section 3, Lecture 4 Antiarrhytmic drugs cont…
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 23 Antiarrhythmic Drugs.
Antidysrhythmic Drugs
Arrhythmias and Antiarrhythmic Drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antidysrhythmic Drugs.
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Circus Movement Classification of antiarrhythmic drugs According to Vaughn-Williams Classification: Class 1: Sodium channel blockersClass 1: Sodium.
CARDIAC ARRHYTHMIA Catherine Seger Medicinal Chemistry.
Antiarrhythmic Agents. BACKGROUND Inside cell: K + ; Outside cell: Na +, Ca + +, Cl - Action potential (AP) and Phase 0-4 phase0---reactivity---conduction---
ANTIARRHYTHMIC DRUGS 1. INTRODUCTION The heart contains specialized cells that exhibit automaticity; that is, they can generate rhythmic action potentials.
Cardiovascular pharmacology.
4-ANTIARRHYTHMIC DRUGS
Drugs for Arrhythmias.
By Ali alalawi. Arrhythmia  Cardiac arrhythmia (also dysrhythmia) is a term for any of a large and heterogeneous group of conditions in which there is.
BIMM118 Cardiac Arrhythmia Arrhythmias : Abnormal rhythms of the heart that cause the heart to pump less effectively Arrhythmia occurs: –when the heart’s.
Antiarrhythmic Drugs Dr. Tom Murray Department of Pharmacology.
Drugs used in the Treatment of Cardiac Arrhythmias
23 Antiarrhythmic Drugs.
Antiarrhythmic Drugs. Drug List Class 1 Sodium Channel Blockers Class 2 Beta-blockers Class 3 Potassium Channel blockers Class 4 Calcium Channel Blockers.
ANTI-ARRHYTHMIC DRUGS
Anti arrhythmic drugs Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics, Phd (physio) Mahatma Gandhi Medical college.
Pharmacology 4 Dr. Khalil Makki. Antiarrhythmic Drugs.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Prof. Abdulrahman Almotrefi
Part 2 Antiarrhythmic Drugs. arrhythmias Abnormal pacemaker, rhythm and AV coordination of heart beats. all arrhythmias result from (1) disturbances in.
ANTI-ARRHYTHMIC DRUGS
* QUINIDINE  Quinidine has pronounced cardiac anti muscarinic effects. It is absorbed orally. It undergoes extensive metabolism by the hepatic cytochrome.
Antiarrhythmic Drugs.
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
Cardiovascular Cardiovascular pharmacology pharmacology.
Anti arrhythmic drugs.
Anti-arrhythmic drugs
Antidysrhythmic Agents
ANTI-ARRHYTHMIC DRUGS
Antiarrhythmic Drugs 7/28/2018.
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Dr.mojiri Pharm-D Pharmacologist
CARDIAC ARRHYTHMIAS & ANTI-ARRHYTHMIC DRUGS
ANTIDYSRHYTHMICS.
Review of Cardiovascular and Renal Drugs
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
Chapter 30 Antiarrhythmic Drugs
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family.
Drugs used in the treatment of arrhythmia I
Presentation transcript:

Dept. of Pharmacology Faculty of Medicine AIMST Antiarrhythmic Drugs Dept. of Pharmacology Faculty of Medicine AIMST

Antiarrhythmic Drugs Lecture Objectives Cardiac Arrhythmias-What are they? Antiarrhythmic Drugs-Classification (Vaughan Williams/Sicilian Gambit/Miscellaneous agents) Pharmacology & uses of : Class I agents (Quinidine/Lidocaine/Phenytoin) Class II agents (Propranolol/Esmolol) Class III agents (Amiodarone) Class IV agents (Verapamil) Miscellaneous agents (Digoxin/Adenosine)

Cardiac Arrhythmias Definition Disorders of within the heart Rate Rhythm Impulse generation or Impulse conduction within the heart Arrhythmias disruption of normal sequence of myocardial activation seriously compromising cardiac mechanical efficiency reducing cardiac output

Antiarrhythmic Drugs Vaughan Williams Classification Class I (Na+ channel blockers) Ia (blocks conduction, ↑ERP) Quinidine Procainamide Disopyramide Ib (blocks conduction, ↓ERP) Lidocaine Mexiletine Phenytoin Ic (blocks conduction, no effect/↑ERP) Encainide Flecainide Propafenone Moricizine

Antiarrhythmic Drugs Vaughan Williams Classification Class II (β-adrenoceptor blockers) Propranolol l -Sotalol Esmolol Class III (K+ channel blockers) Amiodarone Bretylium d -Sotalol N-acetyl-procainamide(Acecainide) Dofetilide Ibutilide

Antiarrhythmic Drugs Vaughan Williams Classification Class IV (Ca2+ channel blockers) Verapamil Diltiazem Bepridil

Antiarrhythmic Drugs Miscellaneous Adenosine Digoxin Magnesium, etc.

Antiarrhythmic Drugs-Major Pharmacological & Electrophysiological Actions Class I Slowing/blocking conduction Class II ↓ SA nodal automaticity Sympatholytic activity Class III No effect on conduction Delay repolarization Class IV Slows conduction velocity in AV node

Antiarrhythmic Drugs (Class Ia) Quinidine Chemistry Dextro isomer of the alkaloid quinine Pharmacological Actions Cardiac Blocks Na+ channels ↓Phase 0 slope (atria/ventricles/Purkinje fibres) ↓Conduction velocity ↑ ERP → ↑ APD

Antiarrhythmic Drugs (Class Ia) Quinidine Pharmacological Actions Extracardiac Quinidine → α-blockade→ Vasodilation ↑ SA node rate ↓ PVR Quinidine ↓ conc. ↑ conc. Indirect Direct effect anticholinergic on cardiac myocytes effects predominate

Antiarrhythmic Drugs (Class Ia) Quinidine Pharmacokinetics Rapidly absorbed from GIT 80% PPB Hepatic metabolism Renal excretion Therapeutic Uses Atrial Fibrillation Atrial Flutter PSVT Premature Ventricular Contractions VT

Antiarrhythmic Drugs (Class Ia) Quinidine Adverse Effects Cardiac AV block ↓ myocardial contractility ↑ cardiac ERP ↑ APD ↑ QT interval ↑ Ventricular tachyarrhythmias (Torsades de pointes) Quinidine Syncope

Antiarrhythmic Drugs (Class Ia) Quinidine Adverse Effects Cardiac -ve inotropic action ↓ BP Cardiac failure GIT Nausea/Vomiting/Diarrhea Cinchonism Tinnitus/Headache

Antiarrhythmic Drugs (Class Ia) Quinidine Drug Interactions Quinidine increases plasma Digoxin concentrations (due to displacement from tissue binding + impairment of renal excretion) DOSE OF DIGOXIN SHOULD BE DECREASED WHEN THE DRUGS ARE USED TOGETHER

Antiarrhythmic Drugs (Class I b) Lidocaine Used principally for ventricular arrhythmias Kinetics makes it unsuitable for oral administration (the drug undergoes extensive presystemic (first-pass) hepatic elimination) Used by the i.v., or occasionally the i.m. route Adverse reactions uncommon unless there is significant cardiac failure or infusion is rapid Adverse effects include hypotension, dizziness, blurred sight, sleepiness, slurred speech, numbness, sweating, confusion and convulsions

Antiarrhythmic Drugs (Class Ib) Phenytoin Orally active anticonvulsant Antiarrhythmic properties similar to those of lidocaine Used to treat ventricular arrhythmias, digitalis overdose-induced arrhythmias, and torsades de pointes

Antiarrhythmic Drugs (Class II) Propranolol Pharmacological Actions β-adrenergic receptor blocker ↓ myocardial contractility (-ve inotropic action) ↓ heart rate (-ve chronotropic action) ↓ Automaticity ↓ Phase 4 slope of diastolic depolarization ↓ AV conduction

Antiarrhythmic Drugs (Class II) Propranolol Therapeutic Uses Supraventricular arrhythmias Re-entry arrhythmias Digoxin-induced arrhythmias Adverse Effects Sedation/Sleep disturbances/Depression Worsening of pre-existing asthma & other forms of airway obstruction Severe hypotension/bradycardia/Heart block or cardiac arrest (from over dosage) Heart failure

Antiarrhythmic Drugs (Class II) Esmolol Pharmacological Actions Very short-acting β1-selective blocker (half-life ~ 9 min) Solely used in cardiac arrhythmias (for intraoperative & other acute arrhythmias) Concomitant IV administration of calcium channel blockers that affect cardiac conduction (e.g. Verapamil, Diltiazem) may lead to intense bradycardia and risk of AV block

Antiarrhythmic Drugs (Class II & III) Sotalol Pharmacological Effects l-Sotalol β-adrenergic blocking activity d-Sotalol Block K+ channels ↓ K+ outward current during repolarization Prolong repolarization ↑ cardiac APD & ERP

Antiarrhythmic Drugs Sotalol (Class II & III) Therapeutic Uses Life-threatening ventricular arrhythmias Maintenance of sinus rhythm in patients with atrial fibrillation Treatment of supraventricular and ventricular arrhythmias in pediatric age group Adverse Effects Extension of its pharmacologic actions Torsade de pointes (dose-dependent)

Antiarrhythmic Drugs (Class III) Amiodarone Pharmacological Actions Possess Class I, II, III & IV actions (broad spectrum) Blocks K+ channels Prolong repolarization ↑ ↑ cardiac APD & ERP

Antiarrhythmic Drugs (Class III) Amiodarone Therapeutic Uses Used in management of severe refractory atrial & ventricular tachyarrhythmias Maintaining normal sinus rhythm in patients with atrial fibrillation (in low doses: 100-200 mg/d) Prevention of recurrent VT

Antiarrhythmic Drugs (Class III) Amiodarone Side Effects Symptomatic bradycardia/Heart block/Polymorphic VT Reversible pulmonary fibrosis Hepatitis Corneal micro deposits (asymptomatic)/Optic neuritis/Blurred vision Skin deposits/photodermatitis/gray-blue discoloration Thyroid abnormalities

Antiarrhythmic Drugs (Class IV) Verapamil Chemistry Phenylalkylamine L-type Ca2+ channel blocker Pharmacological Actions ↓ Ca2+ entry in pacemaker cells (SA & AV nodes) ↓ automaticity

Antiarrhythmic Drugs (Class IV) Verapamil Pharmacological Actions (contd.) ↓ Ca2+ entry via L-type channels into cardiac myocytes ↓ myocardial contractility(-ve inotropic action) ↓ AV node ↓ Re-entry

Antiarrhythmic Drugs (Class IV) Verapamil Therapeutic Uses Supraventricular arrhythmias Re-entrant supraventricular tachycardia Reducing ventricular rate in Atrial Flutter/Atrial Fibrillation Less effective in ventricular arrhythmias Adverse Effects Nausea/Constipation/Headache/Lassitude/ Hypotension/Bradycardia/Heart block

Antiarrhythmic Drugs- Digoxin Therapeutic Uses Atrial Fibrillation/Atrio-ventricular Nodal Tachycardia Digoxin ↑ ERP of AV node ↓ Cond. velo. at AV node ↓ ventricular rate ↓ fatal VF/VT Paroxysmal Atrial Tachycardia

Antiarrhythmic Drugs- Adenosine Chemical Nature Endogenous purine nucleoside Rapidly metabolized by circulating adenosine deaminase Mechanism of Action Activation of an inward rectifier K+ current Hyperpolarization Inhibition of Ca2+ current Suppression of Ca2+ dependent action potentials

Antiarrhythmic Drugs Adenosine (contd.) Pharmacological Actions Brief residence in plasma (several seconds) Slows/Inhibits AV nodal conduction Increases AV nodal refractory period Therapeutic Use Prompt conversion of Paroxysmal Supraventricular Tachycardia to sinus rhythm (90-95% efficacy) A-V Nodal Reentrant Tachycardia & A-V Reciprocating Tachycardia

Antiarrhythmic Drugs Adenosine (contd.) Adverse Effects Flushing (~ 20% patients)/Shortness of breath/Chest burning (perhaps related to bronchospasm)/High-grade AV block/ Headache/Hypotension/Nausea/Paresthesias Drug Interactions Adenosine less effective in presence of adenosine receptor blockers (e.g., Caffeine, Theophylline) Potentiation of action in the presence of adenosine uptake inhibitors (e.g., Dipyridamole)

Antiarrhythmic Drugs Lecture Summary Cardiac Arrhythmias-What are they ? Antiarrhythmic Drugs-Classification Vaughan Williams Sicilian Gambit Miscellaneous agents Class I agents-Quinidine/Lidocaine/ Phenytoin Class II agents-Propranolol/Esmolol Class III agents-Amiodarone Class IV agents-Verapamil Miscellaneous- Digoxin/Adenosine

For Further Reading!.. Basic & Clinical Pharmacology by Bertram G. Katzung (9th Edition)(Chapter 14) Clinical Pharmacology by D. R. Laurence, P. N. Bennett & M. J. Brown (9th Edition) (Chapter 24) Goodman & Gilman’s The Pharmacologic Basis of Therapeutics (10th Edition)(Chapter 35) Drugs for the Heart by Lionel H Opie & Bernard J Gersh (6th Edition)(Chapter 8) Modern Pharmacology with Clinical Applications by Charles R Craig & Robert E Stitzel (6th Edition) (Chapter 16)